Craven House Capital Plc

Equities

CRV

GB00BD4FQ360

Investment Management & Fund Operators

Market Closed - London S.E. Other stock markets 11:35:29 2024-05-28 am EDT			5-day change	1st Jan Change
0.2 ^USD	0.00%		0.00%	+33.33%

Feb. 28	EARNINGS: Hutchmed revenue surges, Craven House's loss widens	AN
Feb. 28	Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023	CI

Craven House Capital plc Reports Earnings Results for the Half Year Ended November 30, 2020

February 18, 2021 at 10:07 am EST

Craven House Capital Plc announced earnings results for the half year ended November 30, 2020. For the half year, the company announced operating loss was GBP 119,000 compared to GBP 5.676 million a year ago. Net loss was GBP 119,000 compared to GBP 5.676 million a year ago. Basic loss per share from continuing operations was GBP 0.0308 compared to GBP 2.237 a year ago.

Latest news about Craven House Capital Plc

EARNINGS: Hutchmed revenue surges, Craven House's loss widens	Feb. 28	AN
Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023	Feb. 28	CI
Amigo interim revenue stoops; remains open to reverse takeover	Dec. 18	AN
EARNINGS AND TRADING: Southern Energy loss swing; Craven House widens	Nov. 29	AN
Craven House Capital Plc Reports Earnings Results for the Full Year Ended May 31, 2023	Nov. 29	CI
FTSE 100 Closes Up 1.25% as Oil Stocks Advance	Nov. 17	DJ
Amigo shares rise a bit after Craven House talks collapse	Nov. 17	AN
FTSE 100 Closes Down 1% as Oil, Mining Stocks Weigh	Nov. 16	DJ
Amigo takeover deal by Craven House Capital investees terminated	Nov. 16	AN
AIM WINNERS & LOSERS: Hotel Chocolat, City Pubs surge on takeover bids	Nov. 16	AN
Amigo Holdings' Potential Reverse Takeover Deal Terminated	Nov. 16	MT
Subprime lender Amigo says 'reverse takeover' deal terminated	Nov. 16	RE
Craven House investee Bio Vitos gets acquisition approval	23-10-23	AN
FTSE 100 Closes Up 0.6% Boosted by Astrazeneca, Outperforming European Peers	23-10-17	DJ
Amigo shares halted amid rescue deal talks with Craven House Capital	23-10-17	AN
Amigo Holdings Flags Early-stage Acquisition Talks with Craven House, Others; Shares Halt Trading in London	23-10-17	MT
UK's Amigo says exploring deals after failing to secure financing	23-10-17	RE
Craven House investee buys shareholding in Hemcheck Sweden	23-08-29	AN
Craven House investee buy by Hemcheck not approved by Nasdaq	23-07-03	AN
I-nexus to deliver growth; Craven House loss narrows	23-02-27	AN
Craven House Capital notes Bio Vitos buys Hemcheck majority	23-02-08	AN
Craven House Capital loss narrows, portfolio valuations unchanged	22-11-29	AN
AIM WINNERS & LOSERS: Safestyle expects full-year profitability hit	22-11-29	AN
Earnings Flash (CRV.L) CRAVEN HOUSE CAPITAL Posts FY22 Loss $-6.11	22-11-29	MT
Craven House Capital Plc Reports Earnings Results for the Full Year Ended May 31, 2022	22-11-29	CI

Chart Craven House Capital Plc

Duration

Period

More charts

Company Profile

Craven House Capital Plc is a United Kingdom-based investment company. The Companyâs investing policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-commerce sector. Its investment portfolio comprises Garimon Limited, Stormfjord Limited, BioVitos Medical Limited, Rosedog Limited, and Honeydog Limited. Garimon Limitedâs assets comprise ownership of the domain www.magazinos.com, a platform for digital magazine distribution. BioVitos Medical Limited has a license to market a patented heart drug, Succifer. Rosedog Limited is the owner of TV Zinos (www.tvzinos.com), a Website which offers a number of free-to-view television channels. The Companyâs investment manager is Desmond Holdings Ltd.

Sector

Investment Management & Fund Operators

Calendar

2024-11-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
CRAVEN HOUSE CAPITAL PLC	+33.33%	773K
BLACKROCK, INC.	-4.98%	115B
UBS GROUP AG	+8.47%	99.65B
BROOKFIELD CORPORATION	+11.82%	67.53B
APOLLO GLOBAL MANAGEMENT, INC.	+23.96%	65.78B
BANK OF NEW YORK MELLON CORPORATION (THE)	+11.89%	43.55B
AMERIPRISE FINANCIAL, INC.	+14.52%	43.2B
3I GROUP PLC	+20.69%	36.01B
T. ROWE PRICE GROUP INC.	+8.02%	25.98B
STATE STREET CORPORATION	-4.58%	22.27B

Other Investment Management & Fund Operators